2014
Dosing and individualized treatment – patient‐centric treatment: changing practice guidelines
Patwa H. Dosing and individualized treatment – patient‐centric treatment: changing practice guidelines. Clinical & Experimental Immunology 2014, 178: 36-38. PMID: 25546754, PMCID: PMC4285483, DOI: 10.1111/cei.12503.Peer-Reviewed Original Research
2012
Evidence-Based Guideline
Li H, Gao X, Hong Y, Patwa H, Chaudhry V, Rae-Grant A, So Y, Alto P. Evidence-Based Guideline. Neurology 2012, 79: 1411. PMID: 23008223, DOI: 10.1212/01.wnl.0000420999.09001.f7.Commentaries, Editorials and LettersEvidence-Based MedicineHumansImmunoglobulins, IntravenousNeurologyNeuromuscular DiseasesTechnology Assessment, BiomedicalEvidence-based guideline
Patwa H, Chaudhry V, Katzberg H, Rae-Grant A, So Y. Evidence-based guideline. Neurology 2012, 78: 1009-1015. PMID: 22454268, DOI: 10.1212/wnl.0b013e31824de293.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsConceptsGuillain-Barré syndromeLambert-Eaton myasthenic syndromeChronic inflammatory demyelinating polyneuropathyTherapeutic classificationSevere myasthenia gravisUse of IVIGInflammatory demyelinating polyneuropathyMiller Fisher syndromeMultifocal motor neuropathyInclusion body myositisEvidence-based guidelinesSerious adverse effectsLong-term treatmentWeb of ScienceDemyelinating polyneuropathyFisher syndromeIVIG efficacyPostpolio syndromeMotor neuropathyMyasthenia gravisBody myositisRoutine treatmentEmbase databasesMyasthenic syndromeIVIG